Abstract
Solid tumors are poorly oxygenated due to insufficient blood supply. Despite that the majority of cells in solid tumor are hypoxic, they both survive and grow under hypoxic conditions. Thus, tumor cells have the ability to adapt to hypoxia, which highly affects the phenotype as well as behavior of distinct cells and the tumor as a whole. Instrumental in this adaptation process, which also occurs in non-transformed cells, are the hypoxia inducible transcription factors HIF-1 and HIF-2 and their oxygen sensitive alpha subunits. In neuroblastoma, a tumor derived from sympathetic nervous system precursor cells, HIF signaling is particularly important as HIF-2α is a marker of unfavorable disease and as it turns out, also of immature neural crest-like, neuroblastoma cells, which is in line with the temporal embryonal expression of HIF-2α during discrete periods of sympathetic nervous system development. Here we review the general mechanisms by which tumor cells adapt to hypoxia and in particular, the role of HIF-2α in aggressive neuroblastoma disease, which primarily is not linked to hypoxic stabilization of HIF-2α, but rather appears to be an inherent property of immature neuroblastoma cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beckwith JB, Perrin EV (1963) In situ neuroblastomas: a contribution to the natural history of neural crest tumors. Am J Pathol 43:1089–1104
Beppu K, Nakamura K, Linehan WM, Rapisarda A, Thiele CJ (2005) Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factorexpression induced by insulin-like growth factor-I in neuroblastoma cells. Cancer Res 65:4775–4781
Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A, Gilbertson RJ (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11:69–82
Chan DA, Giaccia AJ (2010) PHD2 in tumour angiogenesis. Br J Cancer 103:1–5
Covello KL, Kehler J, Yu H, Gordan JD, Arsham AM, Hu CJ, Labosky PA, Simon MC, Keith B (2006) HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 20:557–570
Dimova EY, Kietzmann T (2010) Hypoxia-inducible factors: post-translational crosstalk of signaling pathways. Methods Mol Biol 647:215–236
Favier J, Lapointe S, Maliba R, Sirois MG (2007) HIF2 alpha reduces growth rate but promotes angiogenesis in a mouse model of neuroblastoma. BMC Cancer 7:139
Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438:967–974
Fredlund E, Ringner M, Maris JM, Påhlman S (2008) High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma. Proc Natl Acad Sci USA 105:14094–14099
Hambardzumyan D, Becher OJ, Rosenblum MK, Pandolfi PP, Manova-Todorova K, Holland EC (2008) PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev 22:436–448
Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN (2009) The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 8:3274–3284
Helczynska K, Larsson AM, Holmquist Mengelbier L, Bridges E, Fredlund E, Borgquist S, Landberg G, Påhlman S, Jirström K (2008) Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer. Cancer Res 68:9212–9220
Holmquist-Mengelbier L, Fredlund E, Löfstedt T, Noguera R, Navarro S, Nilsson H, Pietras A, Vallon-Christersson J, Borg A, Gradin K, Poellinger L, Påhlman S (2006) Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10:413–423
Jögi A, Øra I, Nilsson H, Lindeheim A, Makino Y, Poellinger L, Axelson H, Påhlman S (2002) Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 99:7021–7026
Kaelin WG (2005) Proline hydroxylation and gene expression. Annu Rev Biochem 74:115–128
Kvietikova I, Wenger RH, Marti HH, Gassmann M (1995) The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res 23:4542–4550
Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, Hjelmeland AB, Rich JN (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15:501–513
Löfstedt T, Fredlund E, Holmquist-Mengelbier L, Pietras A, Ovenberger M, Poellinger L, Påhlman S (2007) Hypoxia inducible factor-2alpha in cancer. Cell Cycle 6:919–926
Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369:2106–2120
Martens LK, Kirschner KM, Warnecke C, Scholz H (2007) Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator of the TrkB neurotrophin receptor gene. J Biol Chem 282:14379–14388
Martin CM, Ferdous A, Gallardo T, Humphries C, Sadek H, Caprioli A, Garcia JA, Szweda LI, Garry MG, Garry DJ (2008) Hypoxia-inducible factor-2alpha transactivates abcg2 and promotes cytoprotection in cardiac side population cells. Circ Res 102:1075–1081
Nilsson MB, Zage PE, Zeng L, Xu L, Cascone T, Wu HK, Saigal B, Zweidler-McKay PA, Heymach JV (2010) Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors. Oncogene 29:2938–2949
Noguera R, Fredlund E, Piqueras M, Pietras A, Beckman S, Navarro S, Påhlman S (2009) HIF-1alpha and HIF-2alpha are differentially regulated in vivo in neuroblastoma: high HIF-1alpha correlates negatively to advanced clinical stage and tumor vascularization. Clin Cancer Res 15:7130–7136
Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R, Ernestus K, Konig R, Haas S, Eils R, Schwab M, Brors B, Westermann F, Fischer M (2006) Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol 24:5070–5078
Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3:187–197
Pietras A, Gisselsson D, Øra I, Noguera R, Beckman S, Navarro S, Påhlman S (2008) High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche. J Pathol 214:482–488
Pietras A, Johnsson AS, Påhlman S (2010) The HIF-2alpha-driven pseudo-hypoxic phenotype in tumor aggressiveness, differentiation, and vascularization. Curr Top Microbiol Immunol 345:1–20
Puppo M, Battaglia F, Ottaviano C, Delfino S, Ribatti D, Varesio L, Bosco MC (2008) Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha. Mol Cancer Ther 7:1974–1984
Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ (2005) Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von hippel-lindau-associated renal cell carcinoma. Mol Cell Biol 25:5675–5686
Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721–732
Semenza GL (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29:625–634
Straub JA, Sholler GL, Nishi R (2007) Embryonic sympathoblasts transiently express TrkB in vivo and proliferate in response to brain-derived neurotrophic factor in vitro. BMC Dev Biol 7:10
Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL (1998) The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12:3320–3324
Tsarovina K, Schellenberger J, Schneider C, Rohrer H (2008) Progenitor cell maintenance and neurogenesis in sympathetic ganglia involves notch signaling. Mol Cell Neurosci 37:20–31
Vaupel P, Hoeckel M (1999) Predictive power of the tumor oxygenation status. Adv Exp Med Biol 471:533–539
Acknowledgements
This work was supported by the Swedish Cancer Society, the Children’s Cancer Foundation of Sweden, the Swedish Research Council, the SSF Strategic Center for Translational Cancer Research – CREATE Health, BioCARE, a Strategic Research Program at Lund University, Gunnar Nilsson’s Cancer Foundation and the research funds of Malmö University Hospital.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Fredlund, E., Pietras, A., Jögi, A., Påhlman, S. (2012). Neuroblastoma: Role of Hypoxia and Hypoxia Inducible Factors in Tumor Progression. In: Hayat, M. (eds) Neuroblastoma. Pediatric Cancer, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2418-1_13
Download citation
DOI: https://doi.org/10.1007/978-94-007-2418-1_13
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-2417-4
Online ISBN: 978-94-007-2418-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)